Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481897 · ClinicalTrials.gov registry record · NA
Worksite Nutrition Study
A NA study of Type 2 Diabetes and Overweight, sponsored by Physicians Committee for Responsible Medicine.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
- 1
- Study location
NCT00481897: Completed NA study of Type 2 Diabetes and Overweight, sponsored by Physicians Committee for Responsible Medicine.
NCT00481897 is a NA study of Type 2 Diabetes and Overweight that has completed, run by Physicians Committee for Responsible Medicine. The registered enrollment target is 113 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00481897, a NA study of Type 2 Diabetes and Overweight, has completed, sponsored by Physicians Committee for Responsible Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The Worksite Nutrition Study is 22-week translational study aimed at determining how well a worksite-based nutrition program, as compared to a control group, is able to 1) produce clinically significant weight-loss, 2) improve cardiovascular factors, 3) decrease work absenteeism, 4) improve overall quality of life, 5) improve diabetes control in participants with diabetes, and 6) promote dietary adherence and acceptability. The nutrition program for the intervention group consists of once-weekly group meetings where participants will receive group support and nutrition education on a low-fat, vegan diet.
Conditions Studied
Interventions
- BEHAVIORAL low-fat, vegan diet
Study Locations (1)
District of Columbia
- Washington Center for Clinical Research - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-07 |
| Phase | NA |
What the finished NCT00481897 record still lists
NCT00481897 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which low-fat, vegan diet is the first listed.
NCT00481897 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00481897 about?
NCT00481897 is a clinical study titled "Worksite Nutrition Study". The Worksite Nutrition Study is 22-week translational study aimed at determining how well a worksite-based nutrition program, as compared to a control group, is able to 1) produce clinically significant weight-loss, 2) improve cardiovascular factors, 3) decrease work absenteeism, 4) improve overall ...
What is the current status of trial NCT00481897?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2007-05. Estimated completion is 2008-07.
What conditions does trial NCT00481897 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Overweight.
What interventions are being tested in trial NCT00481897?
The interventions under investigation include: low-fat, vegan diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00481897?
This trial is sponsored by Physicians Committee for Responsible Medicine, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00481897 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00481897's enrollment target sits among peer trials
113 142nd of 327 higher than 185 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia